User profiles for Howard Thom
Howard Henry Zappe ThomUniversity of Bristol Verified email at tcd.ie Cited by 1948 |
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Objective To compare the efficacy, safety, and cost effectiveness of direct acting oral
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review, network meta-…
anticoagulants (DOACs) for patients with atrial fibrillation. Design Systematic review, network meta-…
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …
…, JA López-López, GN Okoli, HHZ Thom… - Health Technology …, 2017 - discovery.ucl.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during …
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease during …
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
BACKGROUND: Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk
of thromboembolic events. Anticoagulation therapy to prevent AF-related stroke has been …
of thromboembolic events. Anticoagulation therapy to prevent AF-related stroke has been …
Choice of implant combinations in total hip replacement: systematic review and network meta-analysis
…, RL Humphriss, AD Beswick, HHZ Thom… - bmj, 2017 - bmj.com
Objective To compare the survival of different implant combinations for primary total hip
replacement (THR). Design Systematic review and network meta-analysis. Data sources Medline…
replacement (THR). Design Systematic review and network meta-analysis. Data sources Medline…
[HTML][HTML] Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis
…, M Arber, K Fleetwood, S Toupin, H Thom… - Multiple sclerosis and …, 2019 - Elsevier
Background Ocrelizumab was approved for the treatment of relapsing multiple sclerosis (RMS)
and primary progressive multiple sclerosis (PPMS) by the US Food and Drug …
and primary progressive multiple sclerosis (PPMS) by the US Food and Drug …
Clear or almost clear skin improves the quality of life in patients with moderate‐to‐severe psoriasis: a systematic review and meta‐analysis
Psoriasis Area and Severity Index (PASI) 75 response is currently considered the gold
standard for assessing treatment efficacy in moderate‐to‐severe psoriatic patients. PASI 90 …
standard for assessing treatment efficacy in moderate‐to‐severe psoriatic patients. PASI 90 …
[HTML][HTML] Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses
Background Although bariatric surgery is well established as an effective treatment for patients
with obesity and type 2 diabetes mellitus (T2DM), there exists reluctance to increase its …
with obesity and type 2 diabetes mellitus (T2DM), there exists reluctance to increase its …
Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary …
Objectives To compare outcomes and cost-effectiveness of various initial imaging strategies
in the management of stable chest pain in a long-term prospective randomised trial. Setting …
in the management of stable chest pain in a long-term prospective randomised trial. Setting …
[HTML][HTML] R you still using excel? The advantages of modern software tools for health technology assessment
Economic models are used in health technology assessments (HTAs) to evaluate the cost-effectiveness
of competing medical technologies and inform the efficient use of healthcare …
of competing medical technologies and inform the efficient use of healthcare …
[HTML][HTML] Secukinumab versus adalimumab for psoriatic arthritis: comparative effectiveness up to 48 weeks using a matching-adjusted indirect comparison
Introduction Secukinumab and adalimumab are approved for adults with active psoriatic
arthritis (PsA). In the absence of direct randomized controlled trial (RCT) data, matching-…
arthritis (PsA). In the absence of direct randomized controlled trial (RCT) data, matching-…